SCHEMBL8502391

SCHEMBL8502391

COc1ccc2ncc([Sn](C)(C)C)cc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 7/20 0.55
▸ PDGFRA P16234 7/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ F2 P00734 1/20 0.55
▸ GLA P06280 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ EGFR P00533 3/20 0.54
▸ NCF1 P14598 1/20 0.44
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ NQO2 P16083 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HPGDS O60760 2/20 0.42
▸ NQO1 P15559 1/20 0.41
▸ CASP3 P42574 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378158 0.94 HPGDS (0.51) PDGFRBPDGFRAALDH1A1F2GLA
SCHEMBL8501392 0.87 HPGDS (0.56) PDGFRBPDGFRAALDH1A1EGFRNCF1
SCHEMBL7028923 0.82 ALDH1A1 (0.70) PDGFRBPDGFRAALDH1A1F2GLA
SCHEMBL434861 0.77 PDGFRB (0.59) PDGFRBPDGFRAALDH1A1F2GLA
SCHEMBL9814937 0.77 PDGFRB (0.55) PDGFRBPDGFRAALDH1A1F2GLA
SCHEMBL5952852 0.76 CYP2A6 (0.56) NCF1NPC1RAB9AKDM4EMEN1
SCHEMBL8502977 0.76 PDGFRB (0.53) PDGFRBPDGFRA
SCHEMBL9156972 0.76 ALDH1A1 (0.62) PDGFRBPDGFRAALDH1A1F2GLA
SCHEMBL1928147 0.76 PDGFRB (0.58) PDGFRBPDGFRAALDH1A1F2GLA
SCHEMBL621672 0.76 PDGFRB (0.58) PDGFRBPDGFRAALDH1A1F2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 — — US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 — — US disclosed
US-5656643-A QUINOLIN PYRIDINE DERIVATIVES; USEFUL FOR TREATING CANCER, LEKEMIA, PSORIASIS, INFLAMMATORY DISODERS, BONE DISORDERS, ATHEROSCLEROSIS AND RESTENOSIS; CONTROLLS CELLULAR REPRODUCTION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-08-12 — — US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 — — US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 — — US disclosed
US-5409930-A Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-04-25 — — US disclosed
WO-1992020642-A1 BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-11-26 — — WO disclosed
Send feedback